Latest News
Latest News
Today’s top news highlights: Protests and COVID-19 risk, avoidable epilepsy deaths, and more
“There’s going to be a lot of issues coming out of what’s happened in the last week, but one of them is going to be that chains of transmission...
From the Journals
10% with diabetes hospitalized for COVID-19 die within a week
“Even in diabetes, each increase in BMI is associated with an increase in the risk of intubation and/or death in the 7 days following admission...
Latest News
Mass protests could cause COVID-19 outbreaks
“There’s going to be a lot of issues coming out of what’s happened in the last week, but one of them is going to be that chains of transmission...
Conference Coverage
Treating primary tumor doesn’t improve OS in stage IV breast cancer
Conference Coverage
Pyrotinib bests lapatinib in HER2+ metastatic breast cancer
Patients who received pyrotinib had longer progression-free survival but a higher rate of grade 3 diarrhea.
Conference Coverage
Expanding the role of PARP inhibitors in breast cancer
Conference Coverage
ALTERNATE trial: No fulvestrant benefit in locally advanced ER+ HER2– breast cancer
The endocrine-sensitive disease rate was similar whether patients received anastrozole alone, fulvestrant alone, or fulvestrant plus anastrozole...
Conference Coverage
Tucatinib improves PFS, OS in HER2+ breast cancer with brain metastases
Conference Coverage
TRAIN-2: Anthracyclines added toxicity, with no increased efficacy, in HER2+ breast cancer
Conference Coverage
Capecitabine maintenance improved DFS, not OS, in TNBC patients
The 5-year disease-free survival rate was 83% in the capecitabine arm and 73% in the observation arm.
Conference Coverage
PPI added to chemo improves breast tumor response rate